Latest On Ligand Pharmaceuticals Incorporated (LGND):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-05 02:41 EST | News | Ligand Pharmaceuticals Non-GAAP EPS of $2.28 beats by $1.39, revenue of $43.9M beats by $10.35M | N/A |  |
| 2023-05-05 02:41 EST | News | Ligand Pharma up 5% after hours on 2023 guidance boosts | N/A | |
| 2023-05-05 02:40 EST | News | Ligand Pharmaceuticals Incorporated (LGND) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-04 01:22 EST | News | Ligand Pharmaceuticals Q1 2023 Earnings Preview | N/A | |
| 2023-03-25 18:50 EST | News | Ligand Pharmaceuticals: Expanding Royalty Portfolio And Strong Drug Pipeline | N/A | |
| 2023-02-23 03:25 EST | News | Ligand Pharmaceuticals Non-GAAP EPS of $1.36 beats by $0.24, revenue of $50.38M beats by $10.75M | N/A | |
| 2023-02-23 03:25 EST | News | Ligand Pharmaceuticals, Inc. (LGND) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-22 01:57 EST | News | Ligand Pharmaceuticals Q4 2022 Earnings Preview | N/A | |
| 2023-02-13 21:55 EST | News | OmniAb initiated with a buy at H.C. Wainwright on antibody collaborations, partnerships | N/A | |
| 2023-01-06 13:42 EST | News | Novan submits NDA for berdazimer gel for viral skin infection | N/A | |
| 2022-12-30 10:49 EST | News | A New Ligand Is Taking Shape | N/A | |
| 2022-12-05 10:32 EST | News | Ligand Pharmaceuticals names new CEO | N/A | |
| 2022-11-08 14:51 EST | News | Ligand Pharmaceuticals, Inc. (LGND) Q3 2022 - Earnings Call Transcript | N/A | |
| 2022-11-08 14:50 EST | News | Ligand rises 16% as company sees 2022 earnings above estimates | N/A | |
| 2022-11-07 21:02 EST | News | Ligand Pharmaceuticals Non-GAAP EPS of $0.41 misses by $0.02, revenue of $66.09M beats by $27.76M | N/A | |
| 2022-11-07 04:50 EST | News | Ligand Pharmaceuticals Q3 2022 Earnings Preview | N/A | |
| 2022-11-02 19:30 EST | News | Ligand Pharma jumps 32% as OmniAb completes spinoff and merger | N/A | |
| 2022-10-26 03:29 EST | News | SPAC APAC shareholders approve merger with Ligand spinoff OmniAb | N/A | |
| 2022-09-25 12:04 EST | News | Ligand Pharmaceuticals: Struggling Along | N/A | |
| 2022-09-13 13:35 EST | News | Ligand, Sermonix breast cancer drug lasofoxifene fails to show 'statistical significance' in trial | N/A | |
| 2022-08-09 04:31 EST | News | Ligand Pharmaceuticals Non-GAAP EPS of $1.03 beats by $0.60, revenue of $57.4M beats by $19.67M | N/A | |
| 2022-08-09 04:31 EST | News | Ligand Pharmaceuticals, Inc. (LGND) CEO John Higgins on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-05 05:30 EST | News | Ligand Pharmaceuticals Non-GAAP EPS of $0.76 beats by $0.10, revenue of $45.69M beats by $11.48M | N/A | |
| 2022-05-05 05:30 EST | News | Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-04 08:41 EST | News | Ligand Pharmaceuticals Q1 2022 Earnings Preview | N/A | |
| 2022-03-29 03:41 EST | News | Ligand Pharmaceuticals: Moving Parts Keep Moving | N/A | |
| 2022-02-18 16:58 EST | News | Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-17 19:41 EST | News | Ligand Pharmaceuticals Non-GAAP EPS of $1.80 beats by $0.43, revenue of $72.5M beats by $7.41M | N/A | |
| 2022-02-16 23:33 EST | News | Ligand Pharmaceuticals Q4 2021 Earnings Preview | N/A | |
| 2021-12-31 07:47 EST | News | Ligand: Green Shoots And A Hidden Treasure - A Spinoff Bonus For The New Year | N/A | |
| 2021-12-21 23:48 EST | News | Ligand Pharma, GSK expand existing license deal | N/A | |
| 2021-12-06 17:59 EST | News | NDA for J&J's cilta-cel for multiple myeloma submitted to Japanese regulators | N/A | |
| 2021-11-10 11:00 EST | News | Ligand Pharmaceuticals EPS beats by $0.54, beats on revenue | N/A | |
| 2021-11-10 11:00 EST | News | Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-10 10:59 EST | News | Benchmark keeps buy rating on Ligand following Q3 2021 earnings beat; shares up 7% | N/A | |
| 2021-11-09 11:56 EST | News | Ligand Pharmaceuticals Q3 2021 Earnings Preview | N/A | |
| 2021-10-22 14:43 EST | News | Ligand Pharmaceuticals and China Resources Double-Crane ink collaboration agreement | N/A | |
| 2021-10-11 13:38 EST | News | Ligand's Ailing Remdesivir Cash Cow | N/A | |
| 2021-08-31 10:14 EST | News | Ligand Pharma announces approval of zimberelimab in China for Hodgkin’s lymphoma | N/A | |
| 2021-08-31 10:14 EST | News | PFGC, APPS rise on S&P's latest index shuffles | N/A | |
| 2021-08-16 20:27 EST | News | Travere meets primary efficacy endpoint in late-stage trial for IgA nephropathy (updated) | N/A | |
| 2021-07-30 16:42 EST | News | Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-29 21:14 EST | News | Ligand Pharmaceuticals EPS beats by $0.27, beats on revenue; updates full year guidance | N/A | |
| 2021-07-29 00:39 EST | News | Ligand Pharmaceuticals Q2 2021 Earnings Preview | N/A | |
| 2021-07-21 14:16 EST | News | FDA grants J&J multiple myeloma treatment cilta-cel priority review | N/A | |
| 2021-07-21 13:45 EST | News | Ligand Pharmaceuticals adds Jennifer Cochran to its board of directors | N/A | |
| 2021-07-21 13:43 EST | News | Ligand: 2021 Is Pivotal | N/A | |
| 2021-07-21 13:38 EST | News | Jazz Pharmaceuticals launches leukemia/lymphoma treatment Rylaze | N/A | |
| 2021-05-04 01:21 EST | News | Ligand Pharmaceuticals EPS beats by $0.28, misses on revenue | N/A | |
| 2021-05-04 01:21 EST | News | Ligand swings to Q1 profit, but shares fall more than 6% after hours | N/A | |
About Ligand Pharmaceuticals Incorporated (LGND):
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. The company's commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for the treatment of osteoporosis; Nexterone, a captisol-enabled formulation of amiodarone; Zulresso, a captisol-enabled formulation of brexanolone for the treatment of PPD; Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of postmenopausal osteoporosis; Aziyo portfolio of commercial pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune diseases; Vivitra for breast cancer; Bryxta and Zybev for various indications; and Minnebro for the treatment of hypertension. The company's partners programs, which are in clinical development used for the treatment of cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney, and other diseases. In addition, the company is involved in the sale of Captisol materials. Ligand Pharmaceuticals Incorporated was founded in 1987 and is headquartered in San Diego, California.
General
- Name Ligand Pharmaceuticals Incorporated
- Symbol LGND
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 155
- Last Split Factor1:6
- Last Split Date2010-11-19
- Fiscal Year EndDecember
- IPO Date1992-11-18
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.ligand.com
View More
Valuation
- Trailing PE 4161
- Forward PE 28.99
- Price/Sales (Trailing 12 Mt.) 14.41
- Price/Book (Most Recent Quarter) 3.89
- Enterprise Value Revenue 15.03
- Enterprise Value EBITDA 62.49
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $6.17
- Next Year EPS Estimate $4.86
- Next Quarter EPS Estimate $1.10
- Profit Margin -2%
- Operating Margin 16%
- Return on Assets 1%
- Revenue 186.42 million
- Earnings Per Share $28.29
- Revenue Per Share $11.52
- Gross Profit 96.61 million
- Quarterly Earnings Growth 159.2%
View More
Highlights
- Market Capitalization 2.57 billion
- EBITDA 57.4 million
- PE Ratio 24.1
- PEG Ratio 1.93
- Analyst Target Price $224.67
- Book Value Per Share $44.13
View More
Share Statistics
- Shares Outstanding 16.61 million
- Shares Float 15.81 million
- % Held by Insiders 421%
- % Held by Institutions 146.13%
- Shares Short 2.21 million
- Shares Short Prior Month 2.74 million
- Short Ratio 2.03
- Short % of Float 22%
- Short % of Shares Outstanding 13%
View More
Technicals
- Beta 1.24
- 52 Week High $219.75
- 52 Week Low $66.06
- 50 Day Moving Average 164.68
- 200 Day Moving Average 114.57
View More
Dividends
- Dividend Date N/A
- ExDividend Date 2010-07-02
- Dividend Yield 0%
View More
Ligand Pharmaceuticals Incorporated (LGND) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Ligand Pharmaceuticals Incorporated (LGND) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-03 | $69.99 million | $0.35 | $0.40 | -11.39% |
| 2020-09-30 | 2020-10-30 | $N/A | -$0.42 | $0.53 | -179.62% |
| 2020-06-30 | 2020-08-03 | $N/A | $1.32 | $0.76 | 73.68% |
| 2020-03-31 | 2020-05-06 | $N/A | -$1.46 | $0.12 | -1351.07% |
| 2019-12-31 | 2020-02-06 | $27 million | -$0.43 | -$0.27 | -59.26% |
| 2019-09-30 | 2019-11-05 | $24.81 million | -$0.81 | $0.41 | -297.56% |
| 2019-06-30 | 2019-07-30 | $24.99 million | -$0.74 | $0.66 | -212.98% |
| 2019-03-31 | 2019-05-02 | $43.48 million | $31.32 | $28.86 | 8.54% |
| 2018-12-31 | 2019-02-07 | $59.59 million | -$2.02 | $0.90 | -323.45% |
| 2018-09-30 | 2018-11-08 | $45.66 million | $2.80 | $0.47 | 490.72% |
| 2018-06-30 | 2018-08-06 | $90.04 million | $2.99 | $2.11 | 41.71% |
| 2018-03-31 | 2018-05-08 | $56.16 million | $1.83 | $0.63 | 191.4% |
| 2017-12-31 | 2018-02-21 | $50.46 million | -$0.33 | $0.73 | -145.21% |
| 2017-09-30 | 2017-11-09 | $33.38 million | $0.36 | $0.38 | -4% |
| 2017-06-30 | 2017-08-07 | $28 million | $0.26 | $0.10 | 151.69% |
| 2017-03-31 | 2017-05-09 | $29.27 million | $0.22 | $0.32 | -31.78% |
| 2016-12-31 | 2017-02-23 | $38.19 million | -$0.15 | $0.69 | -121.68% |
| 2016-09-30 | 2016-11-03 | $21.62 million | $0.03 | $0.11 | -71.7% |
| 2016-06-30 | 2016-08-04 | $19.52 million | -$0.28 | $0.05 | -618.52% |
| 2016-03-31 | 2016-05-04 | $29.65 million | $0.30 | $0.38 | -20% |
| 2015-12-31 | 2016-02-10 | $21.19 million | $0.29 | $0.36 | -20% |
| 2015-09-30 | 2015-11-09 | $17.7 million | $0.56 | $0.42 | 33.33% |
| 2015-06-30 | 2015-08-04 | $18.42 million | $1.81 | $0.40 | 352.5% |
| 2015-03-31 | 2015-05-11 | $14.6 million | $0.33 | $0.27 | 22.22% |
| 2014-12-31 | 2015-02-09 | $23 million | $0.60 | $0.60 | 0% |
| 2014-09-30 | 2014-10-27 | $14.97 million | $0.36 | $0.31 | 16.13% |
| 2014-06-30 | 2014-08-04 | $10.61 million | $0.24 | $0.14 | 71.43% |
| 2014-03-31 | 2014-05-07 | $15.96 million | $0.35 | $0.25 | 40% |
| 2013-12-31 | 2014-02-11 | $14.74 million | $0.28 | $0.19 | 47.37% |
| 2013-09-30 | 2013-10-30 | $13.01 million | $0.12 | $0.07 | 71.43% |
| 2013-06-30 | 2013-08-01 | $9.58 million | $0.07 | $0.05 | 40% |
| 2013-03-31 | 2013-05-08 | $11.65 million | $0.16 | $0.09 | 77.78% |
| 2012-12-31 | 2013-02-13 | $13.64 million | $0.19 | $0.21 | -9.52% |
| 2012-09-30 | 2012-11-05 | $6.38 million | -$0.01 | -$0.04 | 75% |
| 2012-06-30 | 2012-08-08 | $5.74 million | -$0.20 | -$0.02 | -900% |
| 2012-03-31 | 2012-05-02 | $5.64 million | -$0.03 | -$0.02 | -50% |
| 2011-12-31 | 2012-02-07 | $12.94 million | $0.24 | $0.07 | 242.86% |
| 2011-09-30 | 2011-11-08 | $5.74 million | -$0.09 | $0.01 | -1000% |
| 2011-06-30 | 2011-08-08 | $7.46 million | -$0.05 | $0.11 | -145.45% |
| 2011-03-31 | 2011-05-10 | $3.9 million | $0.48 | $0.05 | 860% |
| 2010-12-31 | 2011-02-15 | $3.94 million | $0.12 | -$0.03 | 500% |
| 2010-09-30 | 2010-11-09 | $7.8 million | -$3.60 | -$0.03 | -11900% |
| 2010-06-30 | 2010-08-05 | $5.84 million | -$0.01 | -$0.03 | 50.67% |
| 2010-03-31 | 2010-05-05 | $5.96 million | -$0.12 | -$0.18 | 33.33% |
| 2009-12-31 | 2010-02-09 | $13.97 million | $0.06 | -$0.12 | 150% |
| 2009-09-30 | 2009-11-05 | $7.9 million | $0.06 | -$0.24 | 125% |
| 2009-06-30 | 2009-08-03 | $7.59 million | -$0.30 | -$0.41 | 26.83% |
| 2009-03-31 | 2009-05-06 | $9.47 million | -$0.30 | -$0.27 | -11.11% |
| 2008-12-31 | 2009-02-12 | $12.39 million | -$4.56 | -$0.39 | -1069.23% |
| 2008-09-30 | 2008-11-06 | $5.25 million | -$0.60 | -$0.30 | -100% |
| 2008-06-30 | 2008-07-31 | $4.8 million | -$0.30 | -$0.42 | 28.57% |
| 2008-03-31 | 2008-05-01 | $4.87 million | -$0.60 | -$0.27 | -122.22% |
| 2007-12-31 | 2008-02-20 | $5.77 million | $0.36 | -$0.09 | 500% |
| 2007-09-30 | 2007-11-08 | $5.48 million | $0.06 | -$0.12 | 150% |
| 2007-06-30 | 2007-08-08 | $1.41 million | $0.01 | -$0.30 | 103.63% |
| 2007-03-31 | 2007-05-10 | $235000 | $16.32 | $16.68 | -2.16% |
| 2006-12-31 | 2007-03-15 | $140.96 million | $8.52 | $10.14 | -15.98% |
| 2006-09-30 | 2006-11-14 | $-1063000 | -$1.26 | -$0.66 | -90.91% |
| 2006-06-30 | 2006-08-09 | $1.06 million | -$0.96 | -$0.54 | -77.78% |
| 2006-03-31 | 2006-05-15 | $2.91 million | -$11.01 | ||
| 2005-12-31 | 2006-03-16 | $35.7 million | -$0.24 | -$0.54 | 55.56% |
| 2005-09-30 | 2005-11-18 | $32 million | -$1.44 | -$0.85 | -69.41% |
| 2005-06-30 | 2005-08-09 | $18.32 million | -$0.72 | ||
| 2005-03-31 | 2005-05-15 | $36.99 million | -$1.50 | ||
| 2004-12-31 | 2005-02-15 | $67.05 million | $1.02 | $2.55 | -60% |
| 2004-09-30 | 2004-11-09 | $36.77 million | -$0.54 | -$0.06 | -800% |
| 2004-06-30 | 2004-08-03 | $32.27 million | -$1.14 | -$0.36 | -216.67% |
| 2004-03-31 | 2004-05-05 | $27.42 million | -$1.08 | -$0.35 | -208.57% |
| 2003-12-31 | 2004-03-03 | $57.61 million | $0.60 | $0.17 | 252.94% |
| 2003-09-30 | 2003-10-31 | $31.28 million | -$0.96 | -$0.56 | -71.43% |
| 2003-06-30 | 2003-07-28 | $29.13 million | -$1.02 | -$0.83 | -22.89% |
| 2003-03-31 | 2003-04-24 | $23.12 million | -$1.32 | -$0.69 | -91.3% |
| 2002-12-31 | 2003-02-25 | $27.32 million | -$0.54 | $0.02 | -2800% |
| 2002-09-30 | 2002-11-12 | $25.27 million | -$0.60 | -$0.06 | -900% |
| 2002-06-30 | 2002-08-13 | $19.17 million | -$1.02 | -$0.54 | -88.89% |
| 2002-03-31 | 2002-05-03 | $24.89 million | -$0.42 | -$0.06 | -600% |
| 2001-12-31 | 2002-03-11 | $22.64 million | -$0.54 | -$0.70 | 22.86% |
| 2001-09-30 | 2001-10-26 | $19.17 million | -$0.78 | -$0.84 | 7.14% |
| 2001-06-30 | 2001-08-01 | $17.49 million | -$1.08 | -$1.20 | 10% |
| 2001-03-31 | 2001-04-30 | $17.04 million | -$1.20 | -$1.14 | -5.26% |
| 2000-12-31 | 2000-12-31 | $13.83 million | -$1.34 | ||
| 2000-09-30 | 2000-09-30 | $13.59 million | -$1.58 | ||
| 2000-06-30 | 2000-06-30 | $9.87 million | -$1.78 | ||
| 2000-03-31 | 2000-03-31 | $10.82 million | -$1.67 | ||
| 1999-12-31 | 2000-03-10 | -$2.88 | -$1.35 | -113.33% | |
| 1999-09-30 | 1999-11-15 | -$2.34 | -$1.86 | -25.81% | |
| 1999-06-30 | 1999-08-16 | -$2.40 | -$0.78 | -207.69% | |
| 1999-03-31 | 1999-05-13 | -$1.92 | -$1.80 | -6.67% | |
| 1998-12-31 | 1999-03-30 | -$3.54 | -$1.22 | -190.16% | |
| 1998-09-30 | 1998-11-18 | -$2.40 | -$1.23 | -95.12% | |
| 1998-06-30 | 1998-08-14 | -$2.70 | -$2.25 | -20% | |
| 1998-03-31 | 1998-05-18 | -$2.10 | -$2.16 | 2.78% | |
| 1997-12-31 | 1998-02-05 | -$0.54 | -$1.11 | 51.35% | |
| 1997-09-30 | 1997-11-13 | -$2.10 | -$1.80 | -16.67% | |
| 1997-06-30 | 1997-08-14 | -$1.92 | -$1.86 | -3.23% | |
| 1997-03-31 | 1997-05-14 | -$1.92 | -$1.77 | -8.47% | |
| 1996-12-31 | 1997-03-31 | -$2.28 | -$1.88 | -21.28% | |
| 1996-09-30 | 1996-11-08 | -$1.80 | -$1.77 | -1.69% | |
| 1996-06-30 | 1996-08-14 | -$2.16 | -$1.65 | -30.91% | |
| 1996-03-31 | 1996-05-08 | -$1.50 | -$1.59 | 5.66% | |
| 1995-12-31 | 1996-03-28 | -$1.86 | -$1.86 | 0% | |
| 1995-09-30 | 1995-11-14 | -$1.92 | -$0.90 | -113.33% | |
| 1995-06-30 | 1995-08-15 | -$1.14 | -$8.52 | 86.62% | |
| 1995-03-31 | 1995-05-15 | -$1.86 | -$2.64 | 29.55% | |
| 1994-12-31 | 1995-02-16 | -$2.16 | -$2.58 | 16.28% | |
| 1994-09-30 | 1994-10-25 | -$2.52 | -$2.92 | 13.7% | |
| 1994-06-30 | 1994-08-15 | -$3.06 | -$2.58 | -18.6% |
Ligand Pharmaceuticals Incorporated (LGND) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | 21.92 million | N/A | N/A | N/A | 18.66 million |
| Income Before Tax | 3.37 million | N/A | N/A | N/A | -8.18 million |
| Selling General Administrative | 30.08 million | N/A | N/A | N/A | 10.28 million |
| Gross Profit | 58.25 million | N/A | N/A | N/A | 25.07 million |
| Ebit | 6.25 million | N/A | N/A | N/A | -10.18 million |
| Operating Income | -5.9 million | N/A | N/A | N/A | -10.18 million |
| Income Tax Expense | -2.39 million | -4.91 million | 6.03 million | -6.28 million | -810000 |
| Total Revenue | 69.99 million | N/A | N/A | N/A | 27 million |
| Cost of Revenue | 11.74 million | N/A | N/A | N/A | 1.94 million |
| Total Other Income Expense Net | 15.28 million | N/A | N/A | N/A | 2 million |
| Net Income From Continuing Operations | 5.76 million | N/A | N/A | N/A | -7.37 million |
| Net Income Applicable to Common Shares | 5.76 million | -6.7 million | 22.09 million | -24.13 million | -7.37 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | N/A | 795000 | N/A | N/A | N/A |
| Total Cash Flow from Investing Activities | N/A | -26.76 million | N/A | N/A | N/A |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Operating Activities | N/A | 875000 | N/A | N/A | N/A |
| Change in Cash | N/A | N/A | N/A | N/A | N/A |
| Total Cash from Operating Activities | N/A | 24.38 million | N/A | N/A | N/A |
| Depreciation | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Investing Activities | N/A | 2.34 million | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | -1.13 million | N/A | N/A | N/A |
| Change to Net Income | N/A | -16.09 million | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 652.76 million | N/A | N/A | N/A | 702.08 million |
| Total Stockholder Equity | 709.53 million | N/A | N/A | N/A | 767.23 million |
| Other Current Liabilities | 69.32 million | 17.63 million | N/A | N/A | 4.75 million |
| Total Assets | 1.36 billion | N/A | N/A | N/A | 1.47 billion |
| Common Stock | 709.53 million | 697.82 million | 695 million | 661.9 million | 767.23 million |
| Other Current Assets | 3.82 million | 16.33 million | N/A | N/A | 4.73 million |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | 104.71 million | 52.35 million | 66.89 million | 59.15 million | 36.14 million |
| Other Assets | 58.86 million | 52.16 million | 50.04 million | 43.95 million | 9.54 million |
| Cash | N/A | N/A | N/A | N/A | 1.01 billion |
| Total Current Liabilities | 100.11 million | 42.3 million | N/A | N/A | 17 million |
| Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Property, Plant & Equipment | 6.89 million | N/A | N/A | N/A | 10.35 million |
| Total Current Assets | 500.56 million | 857.74 million | N/A | N/A | 1.12 billion |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | -86.45 million | 360.27 million | 365.73 million | 350.65 million | 441.47 million |
| Short Term Investments | N/A | N/A | N/A | N/A | 58.34 million |
| Long Term Debt | 442.29 million | N/A | N/A | N/A | 638.96 million |
| Inventory | 26.49 million | 13.43 million | N/A | N/A | 7.3 million |
| Accounts Payable | 24.2 million | 24.67 million | N/A | N/A | 12.26 million |
Ligand Pharmaceuticals Incorporated (LGND) Chart:
Ligand Pharmaceuticals Incorporated (LGND) News:
Below you will find a list of latest news for Ligand Pharmaceuticals Incorporated (LGND) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Ligand Pharmaceuticals Incorporated (LGND) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 30 | 0 | CALL | 0 | 0 | 325.13 | TRUE | 0 | 0 |
| 2024-05-17 | 35 | 0 | CALL | 0 | 0 | 283.46 | TRUE | 0 | 0 |
| 2024-05-17 | 40 | 0 | CALL | 0 | 0 | 240.35 | TRUE | 0 | 0 |
| 2024-05-17 | 45 | 0 | CALL | 0 | 0 | 199.44 | TRUE | 0 | 0 |
| 2024-05-17 | 50 | 9.25 | CALL | 0 | 0 | 146.62 | TRUE | 0 | 0 |
| 2024-05-17 | 55 | 17.43 | CALL | 0 | 11 | 133.88 | TRUE | 0 | 0 |
| 2024-05-17 | 60 | 10.17 | CALL | 1 | 19 | 93.86 | TRUE | 10.17 | 0 |
| 2024-05-17 | 65 | 15.5 | CALL | 0 | 3 | 37.12 | TRUE | 0 | 0 |
| 2024-05-17 | 70 | 2.62 | CALL | 1 | 42 | 55.43 | TRUE | 2.62 | 0 |
| 2024-05-17 | 75 | 1.25 | CALL | 0 | 64 | 36.58 | FALSE | 0 | 0 |
| 2024-05-17 | 80 | 0.55 | CALL | 0 | 339 | 47.56 | FALSE | 0 | 0 |
| 2024-05-17 | 85 | 0.25 | CALL | 0 | 29 | 90.92 | FALSE | 0 | 0 |
| 2024-05-17 | 90 | 0.95 | CALL | 0 | 45 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 95 | 0.25 | CALL | 0 | 4 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 100 | 0.05 | CALL | 0 | 57 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 105 | 0.36 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 110 | 0.05 | CALL | 0 | 5 | 164.4 | FALSE | 0 | 0 |
| 2024-05-17 | 115 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 120 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 30 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 35 | 0.14 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 40 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 45 | 1.55 | PUT | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 50 | 1.13 | PUT | 0 | 66 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 55 | 0.15 | PUT | 0 | 117 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 60 | 0.95 | PUT | 0 | 13 | 96.53 | FALSE | 0 | 0 |
| 2024-05-17 | 65 | 0.45 | PUT | 0 | 14 | 51.94 | FALSE | 0 | 0 |
| 2024-05-17 | 70 | 2.95 | PUT | 0 | 25 | 30.08 | FALSE | 0 | 0 |
| 2024-05-17 | 75 | 1.55 | PUT | 0 | 2 | 42.35 | TRUE | 0 | 0 |
| 2024-05-17 | 80 | 6.2 | PUT | 0 | 11 | 46.33 | TRUE | 0 | 0 |
| 2024-05-17 | 85 | 11.5 | PUT | 0 | 6 | 56.68 | TRUE | 0 | 0 |
| 2024-05-17 | 90 | 0 | PUT | 0 | 0 | 69.48 | TRUE | 0 | 0 |
| 2024-05-17 | 95 | 0 | PUT | 0 | 0 | 81.21 | TRUE | 0 | 0 |
| 2024-05-17 | 100 | 0 | PUT | 0 | 0 | 92.08 | TRUE | 0 | 0 |
| 2024-05-17 | 105 | 0 | PUT | 0 | 0 | 102.24 | TRUE | 0 | 0 |
| 2024-05-17 | 110 | 29.8 | PUT | 0 | 0 | 111.79 | TRUE | 0 | 0 |
| 2024-05-17 | 115 | 0 | PUT | 0 | 0 | 120.81 | TRUE | 0 | 0 |
| 2024-05-17 | 120 | 0 | PUT | 0 | 0 | 131.55 | TRUE | 0 | 0 |
| 2024-06-21 | 40 | 0 | CALL | 0 | 0 | 140.37 | TRUE | 0 | 0 |
| 2024-06-21 | 45 | 0 | CALL | 0 | 0 | 117.61 | TRUE | 0 | 0 |
| 2024-06-21 | 50 | 0 | CALL | 0 | 0 | 72.57 | TRUE | 0 | 0 |
| 2024-06-21 | 55 | 0 | CALL | 0 | 0 | 46.36 | TRUE | 0 | 0 |
| 2024-06-21 | 60 | 0 | CALL | 0 | 0 | 41.98 | TRUE | 0 | 0 |
| 2024-06-21 | 65 | 0 | CALL | 0 | 0 | 45.53 | TRUE | 0 | 0 |
| 2024-06-21 | 70 | 0 | CALL | 0 | 0 | 42.8 | TRUE | 0 | 0 |
| 2024-06-21 | 75 | 0 | CALL | 0 | 0 | 37.13 | FALSE | 0 | 0 |
| 2024-06-21 | 80 | 1.21 | CALL | 5 | 6 | 38.24 | FALSE | 1.21 | 0 |
| 2024-06-21 | 85 | 0 | CALL | 0 | 0 | 63.56 | FALSE | 0 | 0 |
| 2024-06-21 | 90 | 0 | CALL | 0 | 0 | 72.76 | FALSE | 0 | 0 |
| 2024-06-21 | 95 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 100 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 105 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 110 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 115 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 120 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 40 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 45 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 50 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 55 | 0 | PUT | 0 | 0 | 64.62 | FALSE | 0 | 0 |
| 2024-06-21 | 60 | 0 | PUT | 0 | 0 | 58.15 | FALSE | 0 | 0 |
| 2024-06-21 | 65 | 0 | PUT | 0 | 0 | 42.15 | FALSE | 0 | 0 |
| 2024-06-21 | 70 | 0 | PUT | 0 | 0 | 35.41 | FALSE | 0 | 0 |
| 2024-06-21 | 75 | 0 | PUT | 0 | 0 | 30.21 | TRUE | 0 | 0 |
| 2024-06-21 | 80 | 0 | PUT | 0 | 0 | 26.45 | TRUE | 0 | 0 |
| 2024-06-21 | 85 | 0 | PUT | 0 | 0 | 32.2 | TRUE | 0 | 0 |
| 2024-06-21 | 90 | 0 | PUT | 0 | 0 | 65.6 | TRUE | 0 | 0 |
| 2024-06-21 | 95 | 0 | PUT | 0 | 0 | 35.74 | TRUE | 0 | 0 |
| 2024-06-21 | 100 | 0 | PUT | 0 | 0 | 43.84 | TRUE | 0 | 0 |
| 2024-06-21 | 105 | 0 | PUT | 0 | 0 | 48.24 | TRUE | 0 | 0 |
| 2024-06-21 | 110 | 0 | PUT | 0 | 0 | 58.31 | TRUE | 0 | 0 |
| 2024-06-21 | 115 | 0 | PUT | 0 | 0 | 64.93 | TRUE | 0 | 0 |
| 2024-06-21 | 120 | 0 | PUT | 0 | 0 | 68.91 | TRUE | 0 | 0 |
| 2024-08-16 | 35 | 0 | CALL | 0 | 0 | 87.92 | TRUE | 0 | 0 |
| 2024-08-16 | 40 | 0 | CALL | 0 | 0 | 82.69 | TRUE | 0 | 0 |
| 2024-08-16 | 45 | 0 | CALL | 0 | 0 | 79.93 | TRUE | 0 | 0 |
| 2024-08-16 | 50 | 0 | CALL | 0 | 0 | 66.28 | TRUE | 0 | 0 |
| 2024-08-16 | 55 | 0 | CALL | 0 | 0 | 55.79 | TRUE | 0 | 0 |
| 2024-08-16 | 60 | 0 | CALL | 0 | 0 | 50.36 | TRUE | 0 | 0 |
| 2024-08-16 | 65 | 0 | CALL | 0 | 0 | 47.97 | TRUE | 0 | 0 |
| 2024-08-16 | 70 | 12.5 | CALL | 0 | 12 | 45.35 | TRUE | 0 | 0 |
| 2024-08-16 | 75 | 7.9 | CALL | 0 | 8 | 43.68 | FALSE | 0 | 0 |
| 2024-08-16 | 80 | 8.5 | CALL | 0 | 166 | 42.45 | FALSE | 0 | 0 |
| 2024-08-16 | 85 | 2.8 | CALL | 0 | 618 | 43.29 | FALSE | 0 | 0 |
| 2024-08-16 | 90 | 3.6 | CALL | 0 | 40 | 50.45 | FALSE | 0 | 0 |
| 2024-08-16 | 95 | 0.6 | CALL | 0 | 9 | 42.98 | FALSE | 0 | 0 |
| 2024-08-16 | 100 | 0.4 | CALL | 0 | 6 | 52.36 | FALSE | 0 | 0 |
| 2024-08-16 | 105 | 0.67 | CALL | 0 | 177 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 110 | 0.9 | CALL | 0 | 4 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 115 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 120 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 35 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 40 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 45 | 0.59 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 50 | 1.1 | PUT | 0 | 3 | 69.7 | FALSE | 0 | 0 |
| 2024-08-16 | 55 | 0.52 | PUT | 0 | 1 | 56.03 | FALSE | 0 | 0 |
| 2024-08-16 | 60 | 1.55 | PUT | 0 | 16 | 41.39 | FALSE | 0 | 0 |
| 2024-08-16 | 65 | 2.9 | PUT | 0 | 5 | 31.9 | FALSE | 0 | 0 |
| 2024-08-16 | 70 | 5 | PUT | 0 | 4 | 29.67 | FALSE | 0 | 0 |
| 2024-08-16 | 75 | 7.85 | PUT | 0 | 4 | 26.53 | TRUE | 0 | 0 |
| 2024-08-16 | 80 | 11.35 | PUT | 0 | 46 | 22.13 | TRUE | 0 | 0 |
| 2024-08-16 | 85 | 0 | PUT | 0 | 0 | 43.93 | TRUE | 0 | 0 |
| 2024-08-16 | 90 | 0 | PUT | 0 | 0 | 46.73 | TRUE | 0 | 0 |
| 2024-08-16 | 95 | 10.1 | PUT | 0 | 0 | 48.05 | TRUE | 0 | 0 |
| 2024-08-16 | 100 | 0 | PUT | 0 | 0 | 54.11 | TRUE | 0 | 0 |
| 2024-08-16 | 105 | 0 | PUT | 0 | 0 | 59.81 | TRUE | 0 | 0 |
| 2024-08-16 | 110 | 0 | PUT | 0 | 0 | 65.18 | TRUE | 0 | 0 |
| 2024-08-16 | 115 | 0 | PUT | 0 | 0 | 70.25 | TRUE | 0 | 0 |
| 2024-08-16 | 120 | 0 | PUT | 0 | 0 | 75.04 | TRUE | 0 | 0 |
| 2024-11-15 | 40 | 0 | CALL | 0 | 0 | 86.06 | TRUE | 0 | 0 |
| 2024-11-15 | 45 | 0 | CALL | 0 | 0 | 75.39 | TRUE | 0 | 0 |
| 2024-11-15 | 50 | 24.2 | CALL | 0 | 9 | 67.63 | TRUE | 0 | 0 |
| 2024-11-15 | 55 | 0 | CALL | 0 | 0 | 60.62 | TRUE | 0 | 0 |
| 2024-11-15 | 60 | 0 | CALL | 0 | 0 | 53.99 | TRUE | 0 | 0 |
| 2024-11-15 | 65 | 0 | CALL | 0 | 0 | 49.15 | TRUE | 0 | 0 |
| 2024-11-15 | 70 | 16 | CALL | 0 | 1 | 46.22 | TRUE | 0 | 0 |
| 2024-11-15 | 75 | 8.66 | CALL | 0 | 52 | 46.06 | FALSE | 0 | 0 |
| 2024-11-15 | 80 | 5.9 | CALL | 0 | 70 | 42.09 | FALSE | 0 | 0 |
| 2024-11-15 | 85 | 8.17 | CALL | 0 | 10 | 41.54 | FALSE | 0 | 0 |
| 2024-11-15 | 90 | 2.75 | CALL | 0 | 1 | 41.38 | FALSE | 0 | 0 |
| 2024-11-15 | 95 | 0 | CALL | 0 | 0 | 46.11 | FALSE | 0 | 0 |
| 2024-11-15 | 100 | 0 | CALL | 0 | 0 | 50.79 | FALSE | 0 | 0 |
| 2024-11-15 | 105 | 1.4 | CALL | 0 | 1 | 54.27 | FALSE | 0 | 0 |
| 2024-11-15 | 110 | 0 | CALL | 0 | 0 | 56.87 | FALSE | 0 | 0 |
| 2024-11-15 | 115 | 0 | CALL | 0 | 0 | 58.77 | FALSE | 0 | 0 |
| 2024-11-15 | 120 | 0 | CALL | 0 | 0 | 63.62 | FALSE | 0 | 0 |
| 2024-11-15 | 40 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 45 | 0 | PUT | 0 | 0 | 60.28 | FALSE | 0 | 0 |
| 2024-11-15 | 50 | 1.62 | PUT | 0 | 1 | 50.25 | FALSE | 0 | 0 |
| 2024-11-15 | 55 | 1.91 | PUT | 0 | 7 | 37.13 | FALSE | 0 | 0 |
| 2024-11-15 | 60 | 0 | PUT | 0 | 0 | 31.23 | FALSE | 0 | 0 |
| 2024-11-15 | 65 | 0 | PUT | 0 | 0 | 30.64 | FALSE | 0 | 0 |
| 2024-11-15 | 70 | 5.9 | PUT | 0 | 2 | 28.68 | FALSE | 0 | 0 |
| 2024-11-15 | 75 | 0 | PUT | 0 | 0 | 24.06 | TRUE | 0 | 0 |
| 2024-11-15 | 80 | 0 | PUT | 0 | 0 | 20.29 | TRUE | 0 | 0 |
| 2024-11-15 | 85 | 0 | PUT | 0 | 0 | 30 | TRUE | 0 | 0 |
| 2024-11-15 | 90 | 0 | PUT | 0 | 0 | 32.51 | TRUE | 0 | 0 |
| 2024-11-15 | 95 | 0 | PUT | 0 | 0 | 33.07 | TRUE | 0 | 0 |
| 2024-11-15 | 100 | 0 | PUT | 0 | 0 | 31.96 | TRUE | 0 | 0 |
| 2024-11-15 | 105 | 0 | PUT | 0 | 0 | 37.19 | TRUE | 0 | 0 |
| 2024-11-15 | 110 | 0 | PUT | 0 | 0 | 42.06 | TRUE | 0 | 0 |
| 2024-11-15 | 115 | 0 | PUT | 0 | 0 | 46.63 | TRUE | 0 | 0 |
| 2024-11-15 | 120 | 0 | PUT | 0 | 0 | 50.9 | TRUE | 0 | 0 |
Latest LGND Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 46 | $74.6 |
| Jun 13, 2022 7:59 PM EST | 21 | $74.6 |
| Jun 13, 2022 7:59 PM EST | 10 | $74.52 |
| Jun 13, 2022 7:59 PM EST | 2 | $74.545 |
| Jun 13, 2022 7:59 PM EST | 4 | $74.545 |
Ligand Pharmaceuticals Incorporated (LGND) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000084/0000886163-20-000084-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/886163/000009375120000531/0000093751-20-000531-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/886163/000021545719007313/0000215457-19-007313-index.htm |
| 2020-02-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000076999320000167/0000769993-20-000167-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/886163/000083423720008716/0000834237-20-008716-index.htm |
| 2019-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000005/0000886163-19-000005-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000016/0000886163-19-000016-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000017/0000886163-19-000017-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000018/0000886163-19-000018-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000019/0000886163-19-000019-index.htm |
| 2019-01-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000020/0000886163-19-000020-index.htm |
| 2019-01-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000022/0000886163-19-000022-index.htm |
| 2019-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000024/0000886163-19-000024-index.htm |
| 2019-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000027/0000886163-19-000027-index.htm |
| 2019-02-07 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000029/0000886163-19-000029-index.htm |
| 2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000034/0000886163-19-000034-index.htm |
| 2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000035/0000886163-19-000035-index.htm |
| 2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000036/0000886163-19-000036-index.htm |
| 2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000037/0000886163-19-000037-index.htm |
| 2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/886163/000088616319000041/0000886163-19-000041-index.htm |
| 2019-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000043/0000886163-19-000043-index.htm |
| 2019-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000046/0000886163-19-000046-index.htm |
| 2019-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000049/0000886163-19-000049-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000053/0000886163-19-000053-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000054/0000886163-19-000054-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000055/0000886163-19-000055-index.htm |
| 2019-04-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000059/0000886163-19-000059-index.htm |
| 2019-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/886163/000088616319000063/0000886163-19-000063-index.htm |
| 2019-04-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/886163/000088616319000065/0000886163-19-000065-index.htm |
| 2019-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000071/0000886163-19-000071-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/886163/000088616319000077/0000886163-19-000077-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000080/0000886163-19-000080-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000081/0000886163-19-000081-index.htm |
| 2019-05-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000083/0000886163-19-000083-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000085/0000886163-19-000085-index.htm |
| 2019-05-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000088/0000886163-19-000088-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000090/0000886163-19-000090-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000093/0000886163-19-000093-index.htm |
| 2019-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000095/0000886163-19-000095-index.htm |
| 2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000103/0000886163-19-000103-index.htm |
| 2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000104/0000886163-19-000104-index.htm |
| 2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000105/0000886163-19-000105-index.htm |
| 2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000106/0000886163-19-000106-index.htm |
| 2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000107/0000886163-19-000107-index.htm |
| 2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000108/0000886163-19-000108-index.htm |
| 2019-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000111/0000886163-19-000111-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000114/0000886163-19-000114-index.htm |
| 2019-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000115/0000886163-19-000115-index.htm |
| 2019-07-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000117/0000886163-19-000117-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000120/0000886163-19-000120-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000121/0000886163-19-000121-index.htm |
| 2019-07-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000126/0000886163-19-000126-index.htm |
| 2019-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000130/0000886163-19-000130-index.htm |
| 2019-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000132/0000886163-19-000132-index.htm |
| 2019-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000134/0000886163-19-000134-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000136/0000886163-19-000136-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000138/0000886163-19-000138-index.htm |
| 2019-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000140/0000886163-19-000140-index.htm |
| 2019-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000144/0000886163-19-000144-index.htm |
| 2019-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000145/0000886163-19-000145-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/886163/000088616319000156/0000886163-19-000156-index.htm |
| 2019-08-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/886163/000088616319000157/0000886163-19-000157-index.htm |
| 2019-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000159/0000886163-19-000159-index.htm |
| 2019-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000161/0000886163-19-000161-index.htm |
| 2019-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000163/0000886163-19-000163-index.htm |
| 2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000165/0000886163-19-000165-index.htm |
| 2019-09-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000167/0000886163-19-000167-index.htm |
| 2019-09-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000169/0000886163-19-000169-index.htm |
| 2019-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000174/0000886163-19-000174-index.htm |
| 2019-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000175/0000886163-19-000175-index.htm |
| 2019-09-24 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000177/0000886163-19-000177-index.htm |
| 2019-10-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000184/0000886163-19-000184-index.htm |
| 2019-10-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000186/0000886163-19-000186-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000188/0000886163-19-000188-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616319000191/0000886163-19-000191-index.htm |
| 2019-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/886163/000088616319000199/0000886163-19-000199-index.htm |
| 2019-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000201/0000886163-19-000201-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000206/0000886163-19-000206-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000207/0000886163-19-000207-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000208/0000886163-19-000208-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616319000209/0000886163-19-000209-index.htm |
| 2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616320000002/0000886163-20-000002-index.htm |
| 2020-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616320000007/0000886163-20-000007-index.htm |
| 2020-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616320000009/0000886163-20-000009-index.htm |
| 2020-02-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000014/0000886163-20-000014-index.htm |
| 2020-02-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000015/0000886163-20-000015-index.htm |
| 2020-02-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000016/0000886163-20-000016-index.htm |
| 2020-02-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000017/0000886163-20-000017-index.htm |
| 2020-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/886163/000088616320000025/0000886163-20-000025-index.htm |
| 2020-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000027/0000886163-20-000027-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000029/0000886163-20-000029-index.htm |
| 2020-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616320000034/0000886163-20-000034-index.htm |
| 2020-04-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616320000037/0000886163-20-000037-index.htm |
| 2020-04-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616320000041/0000886163-20-000041-index.htm |
| 2020-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/886163/000088616320000045/0000886163-20-000045-index.htm |
| 2020-04-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/886163/000088616320000046/0000886163-20-000046-index.htm |
| 2020-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000050/0000886163-20-000050-index.htm |
| 2020-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000051/0000886163-20-000051-index.htm |
| 2020-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000052/0000886163-20-000052-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616320000056/0000886163-20-000056-index.htm |
| 2020-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/886163/000088616320000061/0000886163-20-000061-index.htm |
| 2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000063/0000886163-20-000063-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616320000066/0000886163-20-000066-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000074/0000886163-20-000074-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000075/0000886163-20-000075-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000076/0000886163-20-000076-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000077/0000886163-20-000077-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000078/0000886163-20-000078-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000079/0000886163-20-000079-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000080/0000886163-20-000080-index.htm |
| 2020-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000083/0000886163-20-000083-index.htm |
| 2020-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000084/0000886163-20-000084-index.htm |
| 2020-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000087/0000886163-20-000087-index.htm |
| 2020-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616320000092/0000886163-20-000092-index.htm |
| 2020-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/886163/000088616320000097/0000886163-20-000097-index.htm |
| 2020-08-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000099/0000886163-20-000099-index.htm |
| 2020-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616320000101/0000886163-20-000101-index.htm |
| 2020-09-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616320000105/0000886163-20-000105-index.htm |
| 2020-10-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616320000108/0000886163-20-000108-index.htm |
| 2020-10-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616320000110/0000886163-20-000110-index.htm |
| 2020-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616320000112/0000886163-20-000112-index.htm |
| 2020-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000088616320000116/0000886163-20-000116-index.htm |
| 2020-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000088616320000118/0000886163-20-000118-index.htm |
| 2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/886163/000088616320000122/0000886163-20-000122-index.htm |
| 2020-08-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000089924320023546/0000899243-20-023546-index.htm |
| 2020-08-28 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000089924320023644/0000899243-20-023644-index.htm |
| 2020-10-09 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000089924320027886/0000899243-20-027886-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/886163/000091957420001366/0000919574-20-001366-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/886163/000093247119005931/0000932471-19-005931-index.htm |
| 2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/886163/000103738919000060/0001037389-19-000060-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/886163/000103738920000221/0001037389-20-000221-index.htm |
| 2019-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000110465919034623/0001104659-19-034623-index.htm |
| 2019-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000110465919043306/0001104659-19-043306-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/886163/000110465920013156/0001104659-20-013156-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/886163/000110465920018004/0001104659-20-018004-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/886163/000110465920073020/0001104659-20-073020-index.htm |
| 2020-10-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/886163/000110465920113287/0001104659-20-113287-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/886163/000114420419007194/0001144204-19-007194-index.htm |
| 2019-04-15 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/886163/000119312519106750/0001193125-19-106750-index.htm |
| 2019-06-04 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/886163/000119312519165118/0001193125-19-165118-index.htm |
| 2019-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000119312519170732/0001193125-19-170732-index.htm |
| 2019-12-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000119312519322605/0001193125-19-322605-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/886163/000119312520033195/0001193125-20-033195-index.htm |
| 2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000119312520215346/0001193125-20-215346-index.htm |
| 2020-08-11 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/886163/000119312520215349/0001193125-20-215349-index.htm |
| 2020-08-11 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/886163/000119312520215352/0001193125-20-215352-index.htm |
| 2020-08-28 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/886163/000119312520234860/0001193125-20-234860-index.htm |
| 2020-08-31 | SC TO-T | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/886163/000119312520235607/0001193125-20-235607-index.htm |
| 2020-09-11 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/886163/000119312520243535/0001193125-20-243535-index.htm |
| 2020-09-16 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/886163/000119312520246636/0001193125-20-246636-index.htm |
| 2020-09-16 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/886163/000119312520246638/0001193125-20-246638-index.htm |
| 2020-09-30 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/886163/000119312520258665/0001193125-20-258665-index.htm |
| 2020-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/886163/000119312520260585/0001193125-20-260585-index.htm |
| 2020-10-30 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/886163/000119312520282730/0001193125-20-282730-index.htm |
| 2020-01-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/886163/000127417320000002/0001274173-20-000002-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/886163/000156761920003813/0001567619-20-003813-index.htm |
| 2020-06-15 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/886163/999999999720003624/9999999997-20-003624-index.htm |
Ligand Pharmaceuticals Incorporated (LGND) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ligand Pharmaceuticals Incorporated (LGND). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 421%Institutional Ownership: 14613%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-01-23 | Matthew E Korenberg | EVP,Finance & Strategy and CFO | Buy | 2,230.00 | 10,677.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000016/0000886163-19-000016-index.htm | ||
| 2019-01-23 | MATTHEW W FOEHR | President and COO | Buy | 3,547.00 | 116,934.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000018/0000886163-19-000018-index.htm | ||
| 2019-01-23 | MATTHEW W FOEHR | President and COO | Buy | 3,715.00 | 119,365.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000018/0000886163-19-000018-index.htm | ||
| 2019-02-11 | MATTHEW W FOEHR | President and COO | Buy | 7,472.00 | 125,553.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000036/0000886163-19-000036-index.htm | ||
| 2019-01-23 | JOHN L HIGGINS | Chief Executive Officer | Buy | 7,256.00 | 126,465.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000017/0000886163-19-000017-index.htm | ||
| 2019-01-23 | JOHN L HIGGINS | Chief Executive Officer | Buy | 6,390.00 | 129,258.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000017/0000886163-19-000017-index.htm | ||
| 2019-02-11 | JOHN L HIGGINS | Chief Executive Officer | Buy | 12,809.00 | 138,899.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000035/0000886163-19-000035-index.htm | ||
| 2019-03-14 | MATTHEW W FOEHR | President and COO | Buy | 14,894.00 | 9.97 | 148,493.18 | 140,447.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000055/0000886163-19-000055-index.htm |
| 2019-03-13 | JOHN L HIGGINS | Chief Executive Officer | Buy | 2,500.00 | 114.29 | 285,725.00 | 141,399.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000053/0000886163-19-000053-index.htm |
| 2019-06-11 | MATTHEW W FOEHR | President and COO | Buy | 1,004.00 | 21.92 | 22,007.68 | 141,451.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000114/0000886163-19-000114-index.htm |
| 2019-08-12 | MATTHEW W FOEHR | President and COO | Buy | 1,163.00 | 21.92 | 25,492.96 | 142,614.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000159/0000886163-19-000159-index.htm |
| 2019-10-15 | Sarah Boyce | Director | Buy | 1,431.00 | 1,431.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000188/0000886163-19-000188-index.htm | ||
| 2019-09-05 | MATTHEW W FOEHR | President and COO | Buy | 1,005.00 | 21.92 | 22,029.60 | 143,619.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000165/0000886163-19-000165-index.htm |
| 2019-05-14 | JOHN L HIGGINS | Chief Executive Officer | Buy | 2,500.00 | 113.50 | 283,750.00 | 143,899.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000081/0000886163-19-000081-index.htm |
| 2019-11-12 | MATTHEW W FOEHR | President and COO | Buy | 1,001.00 | 21.92 | 21,941.92 | 144,620.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000201/0000886163-19-000201-index.htm |
| 2019-05-31 | JOHN L HIGGINS | Chief Executive Officer | Buy | 1,000.00 | 108.20 | 108,202.00 | 144,899.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000093/0000886163-19-000093-index.htm |
| 2019-07-31 | JOHN L HIGGINS | Chief Executive Officer | Buy | 1,850.00 | 95.45 | 176,582.50 | 146,749.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000134/0000886163-19-000134-index.htm |
| 2020-02-13 | MATTHEW W FOEHR | President and COO | Buy | 496.00 | 21.92 | 10,872.32 | 148,833.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000016/0000886163-20-000016-index.htm |
| 2019-12-20 | MATTHEW W FOEHR | President and COO | Buy | 4,458.00 | 149,078.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000207/0000886163-19-000207-index.htm | ||
| 2019-12-20 | MATTHEW W FOEHR | President and COO | Buy | 2,913.00 | 149,781.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000207/0000886163-19-000207-index.htm | ||
| 2020-02-27 | MATTHEW W FOEHR | President and COO | Sell | 7,225.00 | 110.00 | 794,750.00 | 153,743.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000027/0000886163-20-000027-index.htm |
| 2019-12-20 | JOHN L HIGGINS | Chief Executive Officer | Buy | 7,668.00 | 154,417.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000206/0000886163-19-000206-index.htm | ||
| 2020-08-21 | MATTHEW W FOEHR | President and COO | Buy | 790.00 | 74.42 | 58,791.80 | 155,413.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000099/0000886163-20-000099-index.htm |
| 2020-08-21 | MATTHEW W FOEHR | President and COO | Sell | 7,225.00 | 112.88 | 815,540.66 | 155,413.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000099/0000886163-20-000099-index.htm |
| 2020-08-24 | MATTHEW W FOEHR | President and COO | Sell | 78.00 | 110.89 | 8,649.42 | 155,413.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000099/0000886163-20-000099-index.htm |
| 2020-02-27 | MATTHEW W FOEHR | President and COO | Buy | 1,706.00 | 21.92 | 37,395.52 | 155,449.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000027/0000886163-20-000027-index.htm |
| 2020-08-24 | MATTHEW W FOEHR | President and COO | Buy | 78.00 | 21.92 | 1,709.76 | 155,491.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000099/0000886163-20-000099-index.htm |
| 2020-02-13 | MATTHEW W FOEHR | President and COO | Buy | 7,396.00 | 156,229.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000016/0000886163-20-000016-index.htm | ||
| 2020-02-14 | MATTHEW W FOEHR | President and COO | Sell | 7,225.00 | 95.84 | 692,467.12 | 156,229.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000016/0000886163-20-000016-index.htm |
| 2019-12-20 | JOHN L HIGGINS | Chief Executive Officer | Buy | 5,946.00 | 156,562.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000206/0000886163-19-000206-index.htm | ||
| 2020-03-13 | MATTHEW W FOEHR | President and COO | Buy | 2,000.00 | 21.92 | 43,840.00 | 157,449.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000029/0000886163-20-000029-index.htm |
| 2020-02-27 | MATTHEW W FOEHR | President and COO | Buy | 7,225.00 | 14.47 | 104,545.75 | 160,968.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000027/0000886163-20-000027-index.htm |
| 2020-08-21 | MATTHEW W FOEHR | President and COO | Buy | 7,225.00 | 14.47 | 104,545.75 | 162,638.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000099/0000886163-20-000099-index.htm |
| 2020-02-14 | MATTHEW W FOEHR | President and COO | Buy | 7,225.00 | 14.47 | 104,545.75 | 163,454.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000016/0000886163-20-000016-index.htm |
| 2019-02-11 | Matthew E Korenberg | EVP,Finance & Strategy and CFO | Buy | 6,404.00 | 16,469.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000037/0000886163-19-000037-index.htm | ||
| 2019-09-03 | Matthew E Korenberg | EVP,Finance & Strategy and CFO | Buy | 500.00 | 86.18 | 43,090.75 | 17,151.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000161/0000886163-19-000161-index.htm |
| 2019-12-20 | Matthew E Korenberg | EVP,Finance & Strategy and CFO | Buy | 2,674.00 | 19,825.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000209/0000886163-19-000209-index.htm | ||
| 2020-07-07 | JOHN L HIGGINS | Chief Executive Officer | Buy | 1,165.00 | 85.79 | 99,945.35 | 201,421.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000087/0000886163-20-000087-index.htm |
| 2020-02-13 | JOHN L HIGGINS | Chief Executive Officer | Buy | 48,125.00 | 9.96 | 479,325.00 | 201,739.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000017/0000886163-20-000017-index.htm |
| 2020-07-07 | JOHN L HIGGINS | Chief Executive Officer | Buy | 1,777.00 | 56.26 | 99,974.02 | 203,198.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000087/0000886163-20-000087-index.htm |
| 2020-07-07 | JOHN L HIGGINS | Chief Executive Officer | Buy | 1,373.00 | 74.42 | 102,178.66 | 204,571.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000087/0000886163-20-000087-index.htm |
| 2019-12-20 | Matthew E Korenberg | EVP,Finance & Strategy and CFO | Buy | 2,305.00 | 20,995.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000209/0000886163-19-000209-index.htm | ||
| 2020-02-13 | JOHN L HIGGINS | Chief Executive Officer | Buy | 13,559.00 | 210,289.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000017/0000886163-20-000017-index.htm | ||
| 2019-06-06 | JOHN L LAMATTINA | Director | Buy | 835.00 | 22,284.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000104/0000886163-19-000104-index.htm | ||
| 2019-06-06 | Nancy Ryan Gray | Director | Buy | 835.00 | 2,241.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000106/0000886163-19-000106-index.htm | ||
| 2020-06-10 | Sarah Boyce | Director | Buy | 831.00 | 2,262.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000079/0000886163-20-000079-index.htm | ||
| 2019-07-31 | Stephen L Sabba | Director | Sell | 4,091.00 | 94.45 | 386,394.95 | 23,600.00 | https://www.sec.gov/Archives/edgar/data/886163/000110465919043306/0001104659-19-043306-index.htm |
| 2020-06-10 | Stephen L Sabba | Director | Buy | 831.00 | 24,431.00 | https://www.sec.gov/Archives/edgar/data/886163/000110465920073020/0001104659-20-073020-index.htm | ||
| 2020-06-10 | JOHN L LAMATTINA | Director | Buy | 831.00 | 24,768.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000075/0000886163-20-000075-index.htm | ||
| 2019-08-01 | JOHN L LAMATTINA | Director | Buy | 2,500.00 | 32.30 | 80,750.00 | 24,784.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000138/0000886163-19-000138-index.htm |
| 2019-06-06 | Sunil Patel | Director | Buy | 835.00 | 25,359.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000103/0000886163-19-000103-index.htm | ||
| 2019-05-14 | JOHN W KOZARICH | Director | Sell | 2,500.00 | 112.92 | 282,300.00 | 25,542.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000080/0000886163-19-000080-index.htm |
| 2019-08-02 | Sunil Patel | Director | Buy | 1,000.00 | 95.98 | 95,980.00 | 26,359.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000136/0000886163-19-000136-index.htm |
| 2019-06-06 | JOHN W KOZARICH | Director | Buy | 835.00 | 26,377.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000105/0000886163-19-000105-index.htm | ||
| 2020-02-13 | Matthew E Korenberg | EVP,Finance & Strategy and CFO | Buy | 6,848.00 | 26,864.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000014/0000886163-20-000014-index.htm | ||
| 2020-06-10 | Sunil Patel | Director | Buy | 831.00 | 27,190.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000074/0000886163-20-000074-index.htm | ||
| 2020-06-10 | JOHN W KOZARICH | Director | Buy | 831.00 | 27,208.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000076/0000886163-20-000076-index.htm | ||
| 2019-06-06 | Stephen L Sabba | Director | Buy | 835.00 | 27,691.00 | https://www.sec.gov/Archives/edgar/data/886163/000110465919034623/0001104659-19-034623-index.htm | ||
| 2019-05-14 | JOHN W KOZARICH | Director | Buy | 2,500.00 | 17.88 | 44,700.00 | 28,042.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000080/0000886163-19-000080-index.htm |
| 2020-11-02 | Sunil Patel | Director | Buy | 1,000.00 | 82.52 | 82,520.00 | 28,190.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000118/0000886163-20-000118-index.htm |
| 2020-06-10 | Nancy Ryan Gray | Director | Buy | 831.00 | 3,072.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000077/0000886163-20-000077-index.htm | ||
| 2019-01-10 | Charles S Berkman | SVP, Gen. Counsel & Secretary | Buy | 244.00 | 21.92 | 5,348.48 | 37,307.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000005/0000886163-19-000005-index.htm |
| 2019-01-10 | Charles S Berkman | SVP, Gen. Counsel & Secretary | Buy | 1,931.00 | 74.42 | 143,705.02 | 39,238.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000005/0000886163-19-000005-index.htm |
| 2019-01-10 | Charles S Berkman | SVP, Gen. Counsel & Secretary | Buy | 675.00 | 56.26 | 37,975.50 | 39,913.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000005/0000886163-19-000005-index.htm |
| 2020-06-04 | Charles S Berkman | SVP, Gen. Counsel & Secretary | Sell | 11,146.00 | 118.59 | 1,321,775.16 | 40,877.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000063/0000886163-20-000063-index.htm |
| 2019-01-23 | Charles S Berkman | SVP, Gen. Counsel & Secretary | Buy | 1,370.00 | 41,283.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000019/0000886163-19-000019-index.htm | ||
| 2019-01-23 | Charles S Berkman | SVP, Gen. Counsel & Secretary | Buy | 1,412.00 | 42,695.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000019/0000886163-19-000019-index.htm | ||
| 2019-02-11 | Charles S Berkman | SVP, Gen. Counsel & Secretary | Buy | 3,202.00 | 45,897.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000034/0000886163-19-000034-index.htm | ||
| 2019-08-05 | Charles S Berkman | SVP, Gen. Counsel & Secretary | Buy | 669.00 | 56.26 | 37,637.94 | 46,748.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000144/0000886163-19-000144-index.htm |
| 2019-08-05 | Charles S Berkman | SVP, Gen. Counsel & Secretary | Buy | 424.00 | 85.79 | 36,374.96 | 47,172.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000144/0000886163-19-000144-index.htm |
| 2019-06-06 | Todd C Davis | Director | Buy | 835.00 | 48,474.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000107/0000886163-19-000107-index.htm | ||
| 2019-12-20 | Charles S Berkman | SVP, Gen. Counsel & Secretary | Buy | 1,693.00 | 48,865.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000208/0000886163-19-000208-index.htm | ||
| 2019-08-02 | Todd C Davis | Director | Buy | 1,000.00 | 93.59 | 93,594.40 | 49,474.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000140/0000886163-19-000140-index.htm |
| 2019-12-20 | Charles S Berkman | SVP, Gen. Counsel & Secretary | Buy | 1,335.00 | 49,615.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000208/0000886163-19-000208-index.htm | ||
| 2020-06-10 | Todd C Davis | Director | Buy | 831.00 | 50,305.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000078/0000886163-20-000078-index.htm | ||
| 2019-03-13 | Jason Aryeh | Director | Buy | 202.00 | 112.51 | 22,727.02 | 51,594.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000054/0000886163-19-000054-index.htm |
| 2020-02-13 | Charles S Berkman | SVP, Gen. Counsel & Secretary | Buy | 3,835.00 | 52,904.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000015/0000886163-20-000015-index.htm | ||
| 2020-08-26 | LIGAND PHARMACEUTICALS INC | 10% Share Holder | Sell | 94,488.00 | 8.11 | 766,108.70 | 5,819,383.00 | https://www.sec.gov/Archives/edgar/data/886163/000089924320023546/0000899243-20-023546-index.htm |
| 2019-05-14 | Jason Aryeh | Director | Buy | 250.00 | 112.51 | 28,127.50 | 59,368.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000083/0000886163-19-000083-index.htm |
| 2019-05-20 | Jason Aryeh | Director | Buy | 250.00 | 112.01 | 28,002.50 | 59,618.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000085/0000886163-19-000085-index.htm |
| 2020-08-25 | LIGAND PHARMACEUTICALS INC | 10% Share Holder | Sell | 70,000.00 | 8.02 | 561,575.00 | 5,968,083.00 | https://www.sec.gov/Archives/edgar/data/886163/000089924320023546/0000899243-20-023546-index.htm |
| 2019-05-29 | Jason Aryeh | Director | Buy | 250.00 | 111.01 | 27,752.50 | 59,868.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000090/0000886163-19-000090-index.htm |
| 2019-05-30 | Jason Aryeh | Director | Buy | 250.00 | 110.01 | 27,502.50 | 60,118.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000090/0000886163-19-000090-index.htm |
| 2019-05-31 | Jason Aryeh | Director | Buy | 500.00 | 108.51 | 54,255.00 | 60,618.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000090/0000886163-19-000090-index.htm |
| 2019-06-06 | Jason Aryeh | Director | Buy | 835.00 | 61,453.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000108/0000886163-19-000108-index.htm | ||
| 2019-06-11 | Jason Aryeh | Director | Buy | 250.00 | 107.01 | 26,752.50 | 61,703.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000115/0000886163-19-000115-index.htm |
| 2019-07-29 | Jason Aryeh | Director | Buy | 250.00 | 106.01 | 26,502.50 | 61,953.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000132/0000886163-19-000132-index.htm |
| 2019-07-30 | Jason Aryeh | Director | Buy | 3,000.00 | 100.22 | 300,662.70 | 64,953.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000132/0000886163-19-000132-index.htm |
| 2019-07-31 | Jason Aryeh | Director | Buy | 754.00 | 93.00 | 70,121.55 | 65,707.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000132/0000886163-19-000132-index.htm |
| 2019-08-05 | Jason Aryeh | Director | Buy | 746.00 | 90.01 | 67,145.97 | 66,453.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000145/0000886163-19-000145-index.htm |
| 2019-09-03 | Jason Aryeh | Director | Buy | 750.00 | 87.01 | 65,257.50 | 67,203.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000163/0000886163-19-000163-index.htm |
| 2020-06-10 | Jason Aryeh | Director | Buy | 831.00 | 68,034.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616320000080/0000886163-20-000080-index.htm | ||
| 2019-01-23 | Matthew E Korenberg | EVP,Finance & Strategy and CFO | Buy | 2,418.00 | 9,160.00 | https://www.sec.gov/Archives/edgar/data/886163/000088616319000016/0000886163-19-000016-index.htm |